Thursday, October 8, 2026
The top medical stories of the day, as they ran.
Morning edition
18 stories
- 1WHO seeks more information from Russia about lab worker’s deathInfectious disease · 7 outlets
- 2Caribou halts two cancer cell therapies as it weighs strategic optionsIndustry · 4 outlets
- 3Expert praises Kenya’s response to its first Ebola caseOutbreaks · 2 outlets
- 4Optogenetic gene therapy improved vision in some people with inherited blindnessResearch · 4 outlets
- 5WHO advises against obesity drugs and surgery for children under 10Diabetes and obesity · 2 outlets
- 6Dutch court blocks Merck's subcutaneous Keytruda in eight European countriesDrugs and FDA · 3 outlets
- 7Cerevance reports phase 3 success for Parkinson’s drugDrugs and FDA · 2 outlets
- 8Los Angeles County partners plan system to screen hospital patients for financial aidHealth policy · 2 outlets
- 9PhRMA sues Trump administration over Medicare drug-pricing pilotMedicare and Medicaid · 2 outlets
- 10FDA approves tucatinib combination for HER2-positive breast cancer maintenanceDrugs and FDA · 2 outlets
- 11Study finds fewer emergency visits among foreign-born patients after ICE raidsPublic health · 2 outlets
- 12Study links for-profit hospitals to worse outcomes and nurse staffing shortfallsResearch · 2 outlets
- 13FDA expects to complete mifepristone safety review in March 2027Drugs and FDA · 2 outlets
- 14Trump sends health cost checks and promotes more cash payments before midtermsHealth policy · 2 outlets
- 15Argenx reports celiac trial win and Sjögren's study setbackResearch · 2 outlets
- 16MimiVax vaccine misses primary endpoint in glioblastoma trialCancer · 2 outlets
- 17Study finds U.S. cardiovascular death declines slowed, disparities persistedResearch · 2 outlets
- 18Vanderbilt surgeons adapt heart-recovery technique for pediatric transplantsSurgery · 2 outlets
Evening edition
15 stories
- 1WHO seeks answers about Russian lab worker’s deathInfectious disease · 7 outlets
- 2FDA expects mifepristone safety review report by March 2027Drugs and FDA · 5 outlets
- 3HHS opens NIH clinic to study vaccine injuriesVaccines · 4 outlets
- 4Argenx reports Sjögren’s trial setback and celiac disease successResearch · 4 outlets
- 5Optogenetic gene therapy improved light sensitivity in retinitis pigmentosa trialResearch · 3 outlets
- 6PhRMA sues over Medicare drug-pricing demonstrationMedicare and Medicaid · 3 outlets
- 7FDA expands remibrutinib approval to symptomatic dermographismDrugs and FDA · 2 outlets
- 8Pallone proposes replacing No Surprises Act arbitration processHealth policy · 2 outlets
- 9Los Angeles County partners plan system to screen hospital patients for financial aidHealth policy · 2 outlets
- 10Zealand and Roche report phase 2 results for petrelintideDrugs and FDA · 2 outlets
- 11Caribou halts two cancer cell therapies as it weighs strategic optionsIndustry · 3 outlets
- 12CooperSurgical recalls INCA infant CPAP sets over loose connectionsMedical devices · 1 outlet
- 13Endeavor reports phase 2b success for potential IPF drugResearch · 2 outlets
- 14Study finds maternal flu associations did not persist in sibling analysesResearch · 2 outlets
- 15FDA approves atezolizumab combinations for Stage III dMMR colon cancerDrugs and FDA · 1 outlet